Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Submit a comment

Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction
Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu
Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu
View: Text | PDF
Resource and Technical Advance In-Press Preview Cardiology Cell biology

Integrative 3D imaging and deep learning approach reveals cardiac fibroblast dynamics after myocardial infarction

  • Text
  • PDF
Abstract

Cardiac fibroblasts (CFs) are key mediators of heart failure progression, driving fibrotic scar formation after myocardial infarction (MI). Conventional preclinical assessment of MI relies on two-dimensional histology, which cannot resolve the three-dimensional (3D) architecture of the injured heart. Understanding the molecular mechanisms of CF activation is critical for identifying new drug targets, yet spatial mapping of gene expression in intact hearts remains challenging. To address this, we developed a high-throughput imaging pipeline that combined single-cell–resolution gene expression profiling in cleared whole hearts with light-sheet fluorescence microscopy and an AI-driven analysis framework optimized for MI characterization. Using this approach, we mapped expression of periostin (Postn), collagen triple-helix repeat containing 1 (Cthrc1), and asporin (Aspn) — genes associated with CF activation. These markers were detected by day 3 post-infarction in the endocardium and border zone, preceding collagenous scar formation, then expanded across the infarcted myocardium before declining toward baseline during scar maturation. These findings revealed a spatially organized progression of fibrosis-associated gene expression that began in defined regions of the injured heart and subsequently extended throughout the infarcted myocardium. Whole-organ gene-expression imaging combined with deep-learning-based analysis enabled quantitative spatiotemporal mapping of molecular remodeling and provides a framework for investigating disease progression in intact organs.

Authors

Sheyla Barrado-Ballestero, María López-Moreno, Jorge Cobos-Figueroa, Max Hahn, Cristina Pogontke-Díaz, Tor Biering-Sørensen, Casper G. Salinas, Juan Antonio Guadix, José M. Perez-Pomares, Adrián Ruiz-Villalba, Urmas Roostalu

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts